Nocimed, the leader in the adjunct diagnosis of degenerative disc disease (DDD) pain, has announced that NociScan, a non-invasive test that measures biomarkers associated with disc pain, has launched at Colorado Springs Orthopaedic Group (“CSOG”) in Colorado Springs, Colorado USA, and Spire Nottingham Hospital in the United Kingdom. Since the registration of the NociScan technology …